顯示所有 12 筆結果
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-10.0-BT)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-10.0)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-10.3-BT)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-10.3)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-11.0-BT)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-11.0)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-23.0-BT)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-23.0)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-3.0-BT)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-3.0)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-3.3-BT)
-
Anti-CTLA-4 [CP-675,206 (Tremelimumab, 11.2.1)] (Ab02327-3.3)
